Concurrent changes in 1H MRS metabolites and antioxidant enzymes in the brain of C57BL/6 mouse short-termly exposed to cuprizone: Possible implications for schizophrenia

Cuprizone (CPZ) is a copper chelating agent able to selectively insult mature oligodendrocytes (OLs) in brains of rodents. The CPZ-exposed mice show behavioral changes and have been employed to examine a putative role of altered OLs in the pathophysiology of schizophrenia. The aims of this study were to examine the brain metabolites in the CPZ-exposed mice during the early stage and to measure some antioxidant enzymes, lipid peroxidation and hydrogen peroxide (H2O2) in brain tissue. C57BL/6 mice were fed normal or CPZ-containing diet for 7 days. On days 7 and 8, mice were subjected to behavioral tests. On days 9 and 10, mice were subjected to (1)H MRS procedure. On day 10 mice were sacrificed and their brain tissue was processed for biochemical analyses. CPZ-exposure for 7 days caused an anxiety-like behavior, but had no effect on the social interaction and spatial working memory in C57BL/6 mice. The treatment significantly decreased levels of GPC+PCh, ml, NAA, NAA+NAAG, and PCr in the thalamus and hippocampus. It impaired the activities of some antioxidant enzymes, but did not increase levels of MDA and H2O2. This first (1)H MRS study with CPZ-exposed mice provided neurochemical evidence for mitochondrial dysfunction in brain cells of living mice during the early stage of CPZ-exposure. The results are of relevance to the pathophysiology of schizophrenia in which mitochondrial dysfunction of neural cells and altered OLs are two important players.

[1]  M. Buonocore,et al.  MR spectroscopic studies of the brain in psychiatric disorders. , 2012, Current topics in behavioral neurosciences.

[2]  Haiyun Xu,et al.  Recovery of Behavioral Changes and Compromised White Matter in C57BL/6 Mice Exposed to Cuprizone: Effects of Antipsychotic Drugs , 2011, Front. Behav. Neurosci..

[3]  Sjef Copray,et al.  The cuprizone animal model: new insights into an old story , 2009, Acta Neuropathologica.

[4]  Jullie W Pan,et al.  Interdependence of N‐acetyl aspartate and high‐energy phosphates in healthy human brain , 2005, Annals of neurology.

[5]  J. Kwon,et al.  Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: Investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus , 2009, Schizophrenia Research.

[6]  M. Day,et al.  Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice , 2012, Neuroscience.

[7]  Jeffrey A Lieberman,et al.  Measurement of Brain Metabolites by 1H Magnetic Resonance Spectroscopy in Patients with Schizophrenia: A Systematic Review and Meta-Analysis , 2005, Neuropsychopharmacology.

[8]  Vahram Haroutunian,et al.  Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: A gene ontology study , 2005, Schizophrenia Research.

[9]  F. Goldstein Biosynthesis of N-acetyl-L-aspartic acid. , 1959, Biochimica et biophysica acta.

[10]  H. Cai,et al.  Amyloid plaque pathogenesis in 5XFAD mouse spinal cord: retrograde transneuronal modulation after peripheral nerve injury , 2012, Neurotoxicity Research.

[11]  Takashi Ogino,et al.  In vivo31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest , 2004, The European journal of neuroscience.

[12]  S. Provencher Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.

[13]  C. Aston,et al.  Microarray analysis of postmortem temporal cortex from patients with schizophrenia , 2004, Journal of neuroscience research.

[14]  Haiyun Xu,et al.  Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse , 2008, Schizophrenia Research.

[15]  TRO19622 promotes myelin repair in a rat model of demyelination , 2013, The International journal of neuroscience.

[16]  K. Myhr,et al.  The cuprizone model for demyelination , 2008, Acta neurologica Scandinavica. Supplementum.

[17]  J. Lieberman,et al.  Brain volume in first-episode schizophrenia , 2006, British Journal of Psychiatry.

[18]  Richard Clough,et al.  Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone. , 2009, Behavioral neuroscience.

[19]  Danielle L. Graham,et al.  Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress , 2006, Science.

[20]  Timothy Edward John Behrens,et al.  Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. , 2007, Brain : a journal of neurology.

[21]  R. Edwards,et al.  Alcohol abuse, anaesthesia, and intensive care , 1980, Anaesthesia.

[22]  B. Choe,et al.  Quantitative assessment of neurochemical changes in a rat model of long-term alcohol consumption as detected by in vivo and ex vivo proton nuclear magnetic resonance spectroscopy , 2013, Neurochemistry International.

[23]  M. Keshavan,et al.  Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: A 1H spectroscopy study , 2009, Schizophrenia Research.

[24]  Jong H. Yoon,et al.  GABA Concentration Is Reduced in Visual Cortex in Schizophrenia and Correlates with Orientation-Specific Surround Suppression , 2010, The Journal of Neuroscience.

[25]  D. Liebetanz,et al.  Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis , 2006, Experimental Neurology.

[26]  J. Frahm,et al.  Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.

[27]  P. Morell,et al.  The Neurotoxicant, Cuprizone, as a Model to Study Demyelination and Remyelination in the Central Nervous System , 2001, Brain pathology.

[28]  P. Morell,et al.  Gene Expression in Brain during Cuprizone-Induced Demyelination and Remyelination , 1998, Molecular and Cellular Neuroscience.

[29]  Vikramjeet Singh,et al.  Cuprizone [Bis(Cyclohexylidenehydrazide)] is Selectively Toxic for Mature Oligodendrocytes , 2013, Neurotoxicity Research.

[30]  B. Ho,et al.  Magnetic resonance spectroscopy of limbic structures displays metabolite differences in young unaffected relatives of schizophrenia probands , 2011, Schizophrenia Research.

[31]  Stephen K Fisher,et al.  Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance , 2002, Journal of neurochemistry.

[32]  J Hennig,et al.  Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. , 1994, Gastroenterology.

[33]  Dost Öngür,et al.  Creatine abnormalities in schizophrenia and bipolar disorder , 2009, Psychiatry Research: Neuroimaging.

[34]  Philip D. Harvey,et al.  White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.

[35]  M. Keshavan,et al.  High energy phosphate abnormalities normalize after antipsychotic treatment in schizophrenia: A longitudinal 31P MRS study of basal ganglia , 2010, Psychiatry Research: Neuroimaging.

[36]  Haiyun Xu,et al.  Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination , 2012, Schizophrenia Research.

[37]  Stephen Smith,et al.  Schizophrenia delays and alters maturation of the brain in adolescence. , 2009, Brain : a journal of neurology.

[38]  Diane Stephenson,et al.  Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510) , 2011, NeuroImage.

[39]  R. E. Peterson,et al.  Spectrophotometric Determination of Serum Copper with Biscyclohexanoneoxalyldihydrazone , 1955 .

[40]  Hong-Ju Yang,et al.  Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone , 2014, European Archives of Psychiatry and Clinical Neuroscience.

[41]  Chengren Li,et al.  Cuprizone-induced demyelination in mice: age-related vulnerability and exploratory behavior deficit , 2013, Neuroscience Bulletin.

[42]  M. Keshavan,et al.  Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy , 2013, Schizophrenia Research.

[43]  M. Keshavan,et al.  Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study. , 2004, The American journal of psychiatry.

[44]  P. Ács,et al.  Pathogenesis of multiple sclerosis: what can we learn from the cuprizone model. , 2012, Methods in molecular biology.

[45]  A. Kersting,et al.  Cognitive Impairment and in Vivo Metabolites in First-episode Neuroleptic-naive and Chronic Medicated Schizophrenic Patients: a Proton Magnetic Resonance Spectroscopy Study , 2006 .

[46]  Takahira Yamauchi,et al.  Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[47]  C. Konradi,et al.  Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats , 2009, Schizophrenia Research.

[48]  J. Moffett,et al.  N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.

[49]  G Venturini,et al.  ENZYMIC ACTIVITIES AND SODIUM, POTASSIUM AND COPPER CONCENTRATIONS IN MOUSE BRAIN AND LIVER AFTER CUPRIZONE TREATMENT IN VIVO , 1973, Journal of neurochemistry.

[50]  D. Auer,et al.  In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T. , 2014, Schizophrenia bulletin.

[51]  J. He,et al.  Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes , 2008, Molecular Psychiatry.

[52]  Beatriz Paniagua,et al.  Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver , 2013, Neuron.

[53]  T. Ohmori,et al.  GABA concentration in schizophrenia patients and the effects of antipsychotic medication: A proton magnetic resonance spectroscopy study , 2010, Schizophrenia Research.

[54]  Michael Wagner,et al.  N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia. , 2013, Schizophrenia bulletin.

[55]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Zhijun Zhang,et al.  Locomotor activity and anxiety status, but not spatial working memory, are affected in mice after brief exposure to cuprizone , 2013, Neuroscience Bulletin.

[57]  E. Vilella,et al.  Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination. , 2007, Toxicology letters.